Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

Body image and mental health: The psoriasis connection

As part of mental health awareness week, the Mental Health Foundation (MHF) have released a new report on the interaction between body image and mental health. Our Medical Writer Alex...

Mednet

The UK’s new medicines pricing deal – opportunities and risks for pharma

What pharma needs to know about the new five-year deal

Patients as partners: The future of clinical trial design?

'Patient-centric' is a term that appears in almost all clinical trial communications - but what does it mean and how do we achieve it?

Life Healthcare Communications

- PMLiVE

Snowflake advertising in a burnt-out world

How do you appeal to people who are too tired to care?

Life Healthcare Communications

Why eating people is wrong (and other medical discoveries)

The medical role of rollercoasters, cannibalism, stamp collection and spit & polish were all celebrated in the 2018 IgNobel Prize awards

Life Healthcare Communications

Who is attending this meeting?

When you give a presentation, is your audience focusing on you, your slides, or their smartphones?

Life Healthcare Communications

- PMLiVE

Roche and NHS England hail pricing deal on MS drug Ocrevus

Another pricing deal on high cost medicine

- PMLiVE

Pharmaceutical social media after Cambridge Analytica

As MPs call for the regulation of social media companies, what are the ethical and compliance implications for the pharmaceutical industry?

- PMLiVE

Gene therapy market access Q&A

Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult gives his personal view on how to get the new therapies to patients

- PMLiVE

Bluebird: on a mission to ‘recode’ the DNA of healthcare

Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector

- PMLiVE

Brexit “having impact on EU drug development”

EMA and UK regulator both affected

- PMLiVE

Pfizer buys dwarfism drug company Therachon for $810m

Will rival BioMarin pipeline drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links